Navigation Links
Fuse Science, Inc. DROPS Now Available at PoweredByFuse.com
Date:12/4/2012

MIAMI LAKES, Fla., Dec. 4, 2012 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) an innovative consumer products company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, is pleased to announce that this week's web launch of its PowerFuse™ and ElectroFuse™ DROP products has been met with tremendous excitement.  Both products are now available, along with the Company's EnerJel™ product, on the Powered By Fuse website, www.poweredbyfuse.com.  PowerFuse™ is "All the Energy You Need in a Single DROP™" and ElectroFuse™ is "All the Electrolytes You Need in a Single Drop™." 

"We have been working diligently to insure our launch of the DROP product was a success," said Brian Tuffin, CEO of Fuse Science.  "We feel that both products will redefine their categories.  Our PowerFuse™ product is the 'Evolution of Energy™' while our ElectroFuse™ product will help boost your electrolytes before you compete.  We understand the size and scope of these consumer markets and we are confident that our sporting goods retail distribution strategy will hit our primary demographic with these product."

PowerFuse™
PowerFuse™ is Fuse Science's first Energy formula in a drop.  Administered quickly and easily in the mouth, it allows for optimal absorption, so that you feel energized and are able to perform at your natural best throughout the game, workout or day.  PowerFuse™ contains natural ingredients, causes no sugar crash with zero calories and less than half the caffeine of an 8 oz. cup of premium coffee.  It is available in a great tasting Berry Blast flavor.

ElectroFuse™
ElectroFuse™ is Fuse Science's first Electrolyte formula in a drop.  Administered quickly and easily in the mouth, it allows for optimal absorption of the electrolytes.
ElectroFuse™ contains natural ingredients, causes no sugar crash with zero calories, is easily portable and is available in a great tasting Salty-Sweet flavor.

For additional information on the DROPS including recommended use, please visit: www.poweredbyfuse.com/introducing-powerfuse-and-electrofuse.

Fuse is prioritizing the production of PowerFuse™ and ElectroFuse™ for the planned retail launch and distribution of the DROPS, which is scheduled to begin in January 2013.  The Company is anticipating a high demand for the products and as a result, on-line availability could be limited.  Inventory for on-line ordering will expand as retail placement becomes fulfilled.

"We continue to accelerate production to meet demand and we are positioning ourselves strategically with our manufacturing, marketing and third party logistic partners to effectively meet retail demand which will begin appearing in January," added Tuffin.

If you still don't know what it means to be "Powered By Fuse™" then it's time. Go to www.poweredbyfuse.com and learn more about the products and the company.

About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).For more information:To schedule an interview:Fuse Science, Inc.Gus DeQuesadaInvestor RelationsMichelsen AdvertisingDirect: (305) 503-3873, Ext. 2

C-305-733-1410 / 786-488-7138Email: ir@fusescience.com

prnews@michelsenadvertising.com Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.


'/>"/>
SOURCE Fuse Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
2. In basic science, sometimes it takes individual benefactors like Roys Poyiadjis to fuel innovation
3. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
4. Fuse Science, Inc. adds Major General Robert Dickerson (Ret.) to its Advisory Board
5. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
6. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
7. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
8. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
9. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
10. FUJIFILM Synapse® Mobility 3.0 Now Available In The U.S.
11. Telescope Implant for End Stage Macular Degeneration Now Available Across the Nation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):